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Article Information  ABSTRACT 
Received: 27th November 2019  A simple and selective LC method is described for the determination of Aspirin and Clopidogrel 
in tablet dosage forms. Chromatographic separation was achieved on a c18 column along with 
mobile phase consisting of a combination of fifty five volumes of Mixed Phosphate Buffer and 
forty five volumes of Acetonitrile with detection of 235 nm. Linearity was observed in the range 
20-60 μg/ml for Aspirin (r2=0.998) and 10-30 μg /ml for Clopidogrel (r2 =0.998) for the amount 
of drugs estimated by the projected ways was in smart agreement with the label claim. The 
proposed methods were validated. The accuracy of the methods was assessed by recovery studies 
at three different levels. Recovery experiments indicated the absence of interference from 
commonly encountered pharmaceutical additives. The method was found to be precise as 
indicated by the repeatability analysis, showing %RSD trials. All statistical data proves validity 
of the ways and may be used for routine analysis of pharmaceutical dosage form. 
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Pharmaceutical examination implies examination of 
medications or synthetic elements. Webster' word reference 
depicts a pharmaceutical is a solution. Imaginative work (R&D) 
acknowledge a phenomenally thorough part in new medication 
switch and follow up exercises to guarantee that another 
prescription thing gets the made together gauges is resolute and 
keep embracing by definitive specialists, guaranteeing that all 
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groups of arrangement thing are made to the particular models 
usage of affirmed fixings and creation technique changes into 
the dedication of pharmaceutical examiners in the quality control 
(QC) or quality affirmation (QA) division. The techniques are 
all around made in an investigative R&D division and 
exchanged to QC or assorted working environments as required. 
Once in a while they are exchanged to different divisions [1, 2].  
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Reverse Phase High Performance Liquid Chromatography 
(RP-HPLC) [3] 
Pivot organize chromatography utilizes hydrophobic reinforced 
crushing, by and large with an octadecyl or octyl profitable get-
together and a polar flexible stage, routinely as to some degree 
or absolutely fluid versatile stage. Polar substances lean toward 
the flexible stage and elute first. As the hydrophobic character 
of the solutes expands, bolster increments. By and large, the 
lower the farthest purpose of the versatile stage, the higher is its 
eluent quality. The elution request of the classes of mixes in table 
is rotated (subsequently the name switch organize 
chromatography).  
 
Acetylsalicylic acid (ASA), (2-(acetyloxy) benzoic destructive) 
generally called aspirin (2-(acetyloxy) benzoic destructive), is a 
pharmaceutical used to treat distress, fever, and inflammation. 
Specific provocative conditions in which it is used fuse 
Kawasaki disease, pericarditis, and rheumatic fever. Migraine 
pharmaceutical given not long after a heart attack lessens the risk 
of death [4, 5]. Aspirin is moreover used whole deal to help 
maintain a strategic distance from heart attacks, ischaemic 
strokes, and blood bunches, in people at high risk. The drug may 
in like manner decrease the peril of particular sorts of tumor, 
particularly colorectal cancer. For torment or fever, impacts 
typically begin inside 30 minutes [6, 7]. 
 
Clopidogrel, (methyl (2S)- 2-(2-chlorophenyl)- 2-acetate) an 
antiplatelet administrator in a general sense and 
pharmacologically like ticlopidine, is used to limit blood 
bunches in a collection of conditions, for instance, periphery 
vascular disease, coronary conductor infection, and 
cerebrovascular infirmity. The drug is oversubscribed beneath 
the name medicine by Sanofi and Bristol-Myers Squibb. The 
prescription is an irreversible inhibitor of the P2Y12 adenosine 
diphosphate receptor found on the layers of platelet cells. 
Clopidogrel use is connected with a couple of real hostile 
pharmaceutical reactions, for instance, genuine neutropenia, 
distinctive sorts of release, and cardiovascular edema [8]. Since 
clopidogrel is a prodrug, it must be prepared by CYP450 
chemicals to make the dynamic metabolite that controls platelet 
add up to. This dynamic metabolite particularly stifles adenosine 
diphosphate (ADP) legitimate to its platelet P2Y12 receptor and 
in this way the ADP-interceded activation of the glycoprotein 
GPIIb/IIIa complex, as needs be obstructing platelet gathering 
[9].  
Method development is a continuous process that progresses in 
parallel with the evolution of the drug product. The goal and 
purpose of the method should reflect the phase of drug 
development. During early drug development, the methods may 
focus on API behavior. As drug development progresses, the 
analytical methods are refined and expanded, based on increased 
API and drug product knowledge. Methods should be unique and 
not complicated, to meet the appropriate regulatory guidelines. 
Method validation is the process by which it is established, 
through laboratory studies, that the performance characteristics 
of the method meet the requirements for its intended purpose. It 
is a part of the overall validation process that also includes 
software validation, instrument qualification and system 
suitability [10]. The main aim is to develop new RP HPLC 
procedure for the synchronous analysis of aspirin and 
clopidogrel pharmaceutical dosage outline. The plan of work 
includes – solubility affirmation of aspirin and clopidogrel 
distinctive solvents and pads, determine the digestion maxima of 
both the solutions in UV– Visible locale in different 
solvents/bolsters and picking the solvents for HPLC strategy 
progression. Optimize the adaptable stage and stream rates for 
true blue assurance and upkeep times. Validate the made 
technique as per ICH rules. 
 
MATERIALS AND METHODS 
Instruments Used 
The instruments which were used for this work were, UV Visible 
apparatus which was manufactured by Nicolet evolution 100, 
UV-Visible Software that was developed by Vision Pro, HPLC 
software that was developed by Spin chrome (LC 
SOLUTIONS), HPLC and Electronic balance manufactured by 
Shimadzu(LC 20 AT VP), Ultra sonicator which was 
manufactured Citizen, Digital Ultrasonic Cleaner, pH meter 
manufactured by Global digital, Syringe was used for injection 
which was manufactured by Hamilton, HPLC Column was 
obtained from Inertsil ODS 3V(250x4.6mm) 5μm. 
Reagents Used 
Water, Methanol, Acetonitrile was used according to HPLC 
Grade, Triethyl amine, Orthophosphoric acid was used as per 
AR Grade. 
Drugs Used 
Aspirin and clopidogrel drugs were obtained as gift samples 
from Chandra Labs, Hyderabad. Aspirin – 75mg and clopidogrel 
-75mg (mg) (C-GREL-PLUS) were obtained from pharmacy. 
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Mobile Phase 
A mix of Mixed phosphate pad (pH):ACN were prepared in the 
volume of 50:50 maintaining a pH of 4.0. The flexible stage was 
sonicated for 10 min to remove gasses and isolated through 
0.45μ layer channel for degassing of compact stage. 
 
Methodology 
Determination of wavelength of aspirin and clopidogrel using 
UV Visible spectroscopy [11] 
In simultaneous estimation of two drugs isobestic wavelength is 
used. Isobestic purpose is that the wavelength wherever the 
molar physical property is that the same for both substances that 
area unit interconvertible. So this wavelength is employed in 
synchronous estimation to estimate each medicine accurately. 
Preparation of standard stock solution of aspirin 
10 mg of aspirin was weighed and transferred in to 100ml 
volumetric flask and dissolved in water and then make up to the 
mark with methanol and prepare 10 μg /ml of solution by 
diluting 1ml to 10ml with water. 
Preparation of standard stock solution of clopidogrel 
10 mg of clopidogrel was weighed in to 100ml volumetric flask 
and dissolved in water and then dilute up to the mark with 
methanol and prepare 10 μg /ml of solution by diluting 1ml to 
10ml with water. 
 
Method Development of aspirin and clopidogrel 
Trial - 1 
The mobile phase that was selected for this trial is Di-Potassium 
phosphate K2HPO4 : Methanol at ratio of 55 : 45 maintaining a 
pH of 6.0. Weigh accurately 10 mg of aspirin and 10 mg of 
clopidogrel in 25 ml of volumetric flask and dissolve in 10ml of 
mobile phase and make up the volume with mobile phase.[12] 
From above stock solution 40μg/ml of aspirin and 20μg/ml of 
clopidogrel is prepared by diluting 1.5ml to 10ml with mobile 
phase. This solution is used for recording chromatogram. 
Trial- 2 
The mobile phase that was selected for this trial is Di-Potassium 
phosphate K2HPO4: Acetonitrile: Methanol at ratio of 30:30:40 
maintaining a pH of 4.0.weigh accurately 10 mg of aspirin and 
10 mg of clopidogrel in 25 ml of volumetric flask and dissolve 
in 10ml of mobile phase and make up the volume with mobile 
phase. From above stock solution 40μg/ml of aspirin and 
20μg/ml of clopidogrel is prepared by diluting 1.5ml to 10ml 
with mobile phase. This solution is used for recording 
chromatogram. [13] 
Trial- 3 
The mobile phase that was selected for this trial is mixed 
phosphate buffer: Acetonitrile at ratio of   55: 45 maintaining a 
pH of 4.0.Weigh accurately 10 mg of aspirin and 10 mg of 
clopidogrel in 25 ml of volumetric flask and dissolve in 10ml of 
mobile phase and make up the volume with mobile phase. 
 
From above stock solution 40μg/ml of aspirin and 20μg/ml of 
clopidogrel is prepared by diluting 1.5ml to 10ml with mobile 
phase. This solution is used for recording chromatogram.[14] 
 
Assay 
Preparation of samples for assay [15] 
Preparation of mixed standard solution 
Weigh accurately 10 mg of aspirin and 10 mg of clopidogrel in 
25 ml of volumetric flask and dissolve in 10ml of mobile phase 
and make up the volume with mobile phase. From above stock 
solution 40μg/ml of aspirin and 20μg/ml of clopidogrel is 
prepared by diluting 1.5ml to 10ml with mobile phase. This 
solution is used for recording chromatogram. 
 
Tablet sample 
10 tablets (each tablet contains clopidogrel-75 mg and aspirin -
75 mg) were weighed and taken into a mortar and crushed to fine 
powder and uniformly mixed. Tablet stock solutions of 
clopidogrel and aspirin (μg/ml) were prepared by dissolving 
weight equivalent to 10 mg of clopidogrel and aspirin and 
dissolved in sufficient mobile phase. After that filtered the 
solution using 0.45-micron syringe filter and sonicated for 5 min 
and dilute to 10ml with mobile phase. Further dilutions are 
prepared in 5 replicates of 20μg/ml of clopidogrel and 40μg/ml 
of aspirin was made by adding 1.5 ml of stock solution to 10 ml 
of mobile phase. 
 
Validation [16] 
Specificity by Direct comparison method 
There is no interference of mobile part, solvent and placebo with 
the analyte peak and conjointly the height purity of analyte peak 
that indicate that the tactic is particular for the analysis of 
analyte’s in their dosage form. 
 
Standard sample: 
Weigh accurately 10 mg of aspirin and 10 mg of clopidogrel in 
25 ml of volumetric flask and dissolve in 10ml of mobile phase 
and make up the volume with mobile phase. From above stock 
Journal of Applied Pharmaceutical Research 8 (3); 2020: 38 – 47 Sreekanth et. al  
 
 
  Journal of Applied Pharmaceutical Research (JOAPR)| July – September 2020 | Volume 8 Issue 3 |   41 
solution 40μg/ml of aspirin and 20μg/ml of clopidogrel is 
prepared by diluting 1.5ml to 10ml with mobile phase. This 
solution is used for recording chromatogram 
 
Tablet sample 
10 tablets (each tablet contains clopidogrel -75 mg and aspirin -
75 mg) were weighed and taken into a mortar and crushed to fine 
powder and uniformly mixed. Tablet stock solutions of aspirin 
and clopidogrel (μg/ml) were prepared by dissolving weight 
equivalent to 10 mg of aspirin and clopidogrel and dissolve it in 
sufficient mobile phase. After that filtered the solution using 
0.45-micron syringe filter and Sonicated for 5 min and dilute to 
10ml with mobile phase. Further dilutions are prepared in 5 
replicates of 20μg/ml of clopidogrel and 40μg/ml of aspirin was 
made by adding 1.5 ml of stock solution to 10 ml of mobile 
phase. 
 
Linearity and range 
Preparation of standard stock solution 
Standard stock solutions of aspirin and clopidogrel (μg /ml) were 
prepared by dissolving 10 mg of aspirin and clopidogrel which 
is dissolved in sufficient mobile phase and dilute to 100 ml with 
mobile phase. The relationship between the concentration and 
area of aspirin and clopidogrel should be linear in the specified 
range and the correlation should not be less than 0.99. 
 
Tablet sample 
10 tablets (each tablet contains Clopidogrel-75 mg and Aspirin - 
75 mg) were weighed and taken into a mortar and crushed to fine 
powder and uniformly mixed. Tablet stock solutions of aspirin 
and clopidogrel (μg/ml) were prepared by dissolving weight 
equivalent to 10 mg of aspirin and clopidogrel and dissolved in 
sufficient mobile phase. After that filtered the solution using 
0.45-micron syringe filter and Sonicated for 5 min and dilute to 
10ml with mobile phase. Further dilutions are prepared in 5 
replicates of 20μg/ml of clopidogrel and 40μg/ml of aspirin was 




Accuracy of the tactic determined by recovery studies. To the 
formulation (pre analyzed sample), the reference standards of 
the drugs were added at the level of 100%, 120%, 140%. The 
recovery studies were dole out thrice and also the share recovery 
and share mean recovery were calculated for drug is shown in 
table. To check the accuracy of the maneuver, recovery studies 
were disbursed by addition of ordinary drug resolution to pre- 




Prepared sample preparations of CLOPIDOGREL and 
ASPIRIN as per test method and injected 6 times in to the 
column. The % Relative standard deviation of Assay 
preparations of CLOPIDOGREL and ASPIRIN should be not 
more than 2.0%. 
 
Limit of Detection (LOD) 
The detection limit of a private analytical procedure is that the 
lowest quantity of analyte which may be detected however not 
essentially quantitated as a precise worth. It is a limit check that 
specifies whether or not associate analyte is on top of or below 
an exact worth. The standard deviation of the response can be 
determined based on the standard deviation of the blank, on the 
residual standard deviation of the regression line, or the standard 
deviation of y-intercepts of regression lines. 
 
Limit of Quantitation (LOQ) 
The limit of quantitation is outlined because the lowest 
concentration of associate analyte which will be determined with 
acceptable preciseness and accuracy underneath the explicit 
operational conditions of the method. Again, the standard 
deviation of the response can be determined based on the 
standard deviation of the blank, on the residual standard 
deviation of the regression line, or the standard deviation of y-
intercepts of regression lines. 
 
Robustness 
To demonstrate the strength of the tactic, prepared solution as 
per test method and injected at different variable conditions like 
using different conditions like flow rate and wavelength. System 
suitableness parameters were compared therewith of technique 
preciseness. The system suitableness ought to pass as per the 
check technique at variable conditions. 
 
Ruggedness 
The ruggedness of the method was studied by the determining 
the analyst to analyst variation by performing the assay by two 
different analysts. The % Relative standard deviation of assay 
values between two analysts should be not more than 2.0%. 
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RESULTS AND DISCUSSIONS  
Determination of wavelength of aspirin and clopidogrel using UV Visible spectroscopy  
 
(X-axis – Wavelength and Y – axis – absorbance) 
The Isobestic point was found to be 235 nm for aspirin and clopidogrel in combination 
 
Method Development of aspirin and clopidogrel – Trial – 01. (X – Axis – Time, Y – axis – Voltage) 
 
 
Although the Efficiency was not satisfactory for aspirin and the peak response of clopidogrel was very less. The retention time is 
more. Hence it was not taken for optimization. 
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Method Development of aspirin and clopidogrel – Trial – 02. (X – Axis – Time, Y – axis – Voltage) 
 
The efficiency of aspirin was not satisfactory. Hence it was not taken for optimization. 
 
Method Development of aspirin and clopidogrel – Trial – 03. (X – Axis – Time, Y – axis – Voltage) 
 
All the system suitability requirements were met. The peak Asymmetry factor was less than 2 for both aspirin and clopidogrel. The 
efficiency was more than 2000 aspirin and clopidogrel .Resolution between two peaks >1.5. Hence this method was for optimized. 
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Assay Results 
 Aspirin Clopidogrel 
Standard Area Sample Area Standard Area Sample Area 
Injection-1 1487.1 1487.447 410.632 409.505 
Injection-2 1483.265 1488.48 404.609 409.228 
Injection-3 1488.429 1483.804 409.31 408.099 
Injection-4 1489.131 1488.429 411.211 409.31 
Injection-5 1483.538 1487.1 407.001 405.125 
Average Area 1486.293 1487.052 408.5526 408.2534 
Assay(%purity) 100.051094 99.9267659 
The amount of aspirin and clopidogrel present in the taken dosage form was found to be 100.05 % and 99.92 % respectively. 
 
Validation 
Specificity by Direct comparison method (X – Axis – Time, Y – axis – Voltage) (Blank and Sample) 
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It is observed from the above data, diluent or excipient peaks are not interfering with the aspirin and clopidogrel peaks. 
 
Linearity of Aspirin and Clopidogrel 
 Aspirin Clopidogrel 
S. No. Conc.(µg/ml ) Area Conc.(µg/ml ) Area 
1 20 727.341 10 211.784 
2 30 1035.752 15 322.204 
3 40 1377.14 20 428.317 
4 50 1722.958 25 520.564 
5 60 2041.082 30 627.846 
Aspirin                                                                                            Clopidogrel 
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The correlation coefficient for linear curve obtained between concentrations vs. Area for standard preparations of aspirin and 
clopidogrel is 0.998 and 0.998. The relationship between the concentration of aspirin and clopidogrel and area of aspirin and 
clopidogrel is linear in the range examined since all points lie in a straight line and the correlation coefficient is well within limits. 
 
Accuracy results of aspirin 
Recovery 
level 
Accuracy Aspirin Average % 
Recovery Amount taken(mcg/ml) Area %Recovery 























The percentage mean recovery of aspirin and clopidogrel is 99.19 and 99.89 % respectively. 
 
Results for Method Precision of aspirin and clopidogrel 
S. No. 
Aspirin Clopidogrel 
Rt Area Rt Area 
1 3.145 978370.000 6.211 340457 
2 3.165 962064.000 6.224 341907 
3 3.151 967422.000 6.212 339323.000 
4 3.148 955774.000 6.194 339473.000 
5 3.126 951906.000 6.168 339074 
6 3.116 962532.000 6.170 340503.000 
Avg 3.1418 963011.333 6.197 340122.833 
St dev 0.0178 9297.067 0.023 1058.443 
%RSD 0.57 0.97 0.38 0.31 
Test results for Clopidogrel and Aspirin are showing that the %RSD of Assay results are within limits. 
 




Retention time(min) Tailing factor Retention time(min) Tailing factor 
Flow Rate     
0.8 ml/min 2.562 1.679 5.059 1.263 
1.2 ml/min 2.148 1.678 4.235 1.264 
Wavelength     
233nm 2.566 1.687 5.052 1.262 
237nm 2.570 1.686 5.065 1.265 
 
From the observation it was found that the system suitability parameters were within limit at all variable conditions. 
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Results for Ruggedness 
Aspirin %Assay Clopidogrel %Assay 
Analyst 01 100.5 Analyst 01 98.9 
Anaylst 02 99.5 Anaylst 02 100.6 
 From the observation the between 2 analysts Assay values not higher than 2.0%, therefore the strategy was rugged. 
 
CONCLUSION 
From the above experimental results and parameters it was 
concluded that, this newly developed method for the 
simultaneous estimation aspirin and clopidogrel was found to be 
simple, precise, accurate and high resolution and shorter 
retention time makes this method more acceptable and cost 
effective and it can be effectively applied for routine analysis in 
research institutions, quality control department in meant in 
industries, approved testing laboratories studies in near future. 
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